LCGC
BIIB icon

Legacy Capital Group California’s Biogen BIIB Stock Holding History

Legacy Capital Group California’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Sell
2,844
-57
-2% -$10.9K 0.19% 162
2026
Q1 		$532K Buy
+2,901
New +$535K 0.2% 165
2024
Q4 		– Sell
-1,798
Closed -$349K – 336
2024
Q3 		$349K Buy
1,798
+162
+10% +$33.9K 0.12% 203
2024
Q2 		$379K Buy
1,636
+595
+57% +$129K 0.14% 198
2024
Q1 		$224K Buy
1,041
+65
+7% +$15.2K 0.08% 281
2023
Q4 		$253K Buy
976
+110
+13% +$27K 0.1% 247
2023
Q3 		$223K Buy
866
+112
+15% +$30K 0.1% 252
2023
Q2 		$215K Buy
+754
New +$224K 0.09% 251

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Legacy Capital Group California's BIIB Position: Q2 2026 in Review

Legacy Capital Group California reduced its Biogen (BIIB) stake by 2% in Q2 2026, selling an estimated $10.9K and leaving 2,844 shares worth $614K. The position accounts for 0.19% of the portfolio, ranked #162.

Legacy Capital Group California first reported a position in BIIB in Q2 2023 and has held it in 8 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Legacy Capital Group California held 2,844 shares of Biogen worth $614K as of Q2 2026.
  • Legacy Capital Group California sold 57 Biogen shares in Q2 2026, an estimated $10.9K.
  • Biogen made up 0.19% of Legacy Capital Group California's portfolio in Q2 2026, its #162 holding.
  • Legacy Capital Group California first reported a position in Biogen in Q2 2023 and has held it in 8 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Legacy Capital Group California's 13F filing for Q2 2026, filed 29 Jul 2026.